Fundraising FoxLYFE Capital — Full Portfolio
25 tracked investments · listed companies and verified rows first
Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system.
BiotechDeep TechSemiconductorsBoston, US
Jeffrey Abbott(Co-Founder & CEO)inDuane Sword(Co-Founder & CBO)inDonhee Ham(Scientific Co-Founder)inHongkun Park(Scientific Co-Founder)Vince (Wenxuan) Wu(Founder)inWenxuan Wu(Executive Officer, Director)
Co-investorsAnzu PartnersBantam GroupDraper AssociatesBoxOne Ventures
Guokang is a Chinese health management company providing private-doctor and corporate health management services, primarily to executives and directors of large enterprises, along with health insurance brokerage and an online health-management SaaS platform.
Digital HealthHealthtechSaaSWellness & FitnessShenzhen, CN
杨华山(Chairman & CEO)Yang Huashan(Chairman & CEO)
Co-investorsQiming Venture Partners
iECURE is a clinical-stage biotechnology company developing in vivo genome editing therapies that insert a functional copy of a gene into a patient's genome to treat rare, life-threatening genetic diseases in children.
BiotechHealthtechMedical Devices
James M. Wilson(Scientific Founder)Joseph Truitt(CEO & Board Member)inPaul Firuta(COO)inAlex Monteith(Chief Business Officer)David Garrett(CFO)inGabriel M. Cohn(Chief Medical Officer)in
Co-investorsOrbiMedVersant Ventures
Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)inANDRÉS BRATT-LEAL, Ph.D.(Co-Founder; Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)inDAMIEN MCDEVITT, Ph.D.(President and Chief Executive Officer)
Co-investorsARCH Venture PartnersLifeforce CapitalOrbiMedDomain AssociatesEDB InvestmentsSection 32+10 more
Bora Pharmaceuticals is a pharmaceutical services company offering CDMO (contract development and manufacturing) for both small molecule and large molecule/biologics products, alongside its own drug development focused on specialty pharma and rare diseases.
Advanced ManufacturingBiotechHealthtech
Bobby Sheng(Founder)in
HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics.
AI & Machine LearningBiotechHealthtech
Liang Schweizer(Founder)in
Co-investorsB Capital GroupB4 CapitalTrinity Innovation Bioventure SingaporeIDG CapitalLegend CapitalNest.Bio Ventures+1 more
.jpeg){kind=logo}
An enterprise that develops and commercializes biomedical materials and biopharmaceutical products, including Class III and Class II medical devices, dermal fillers, facial threads, and proteins/peptides for medical aesthetics, dermatology, surgery, metabolic disease, and professional skincare.
BiotechHealthtechMedical DevicesWellness & FitnessBeijing, CN
Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.
BiotechDeep TechNew MaterialsSan Diego, US
J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)Michael J. Kamdar(President, Chief Executive Officer and Secretary)Bill Efcavitch(Founder)Curt Becker(Founder)
BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)
Co-investors11.2 CapitalDCVC (Data Collective)iSelect FundKeshif VenturesRising TideAlexandria+2 more
Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.
BiotechDeep TechHealthtechSouth San Francisco, US
Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)inCatherine Priest(Chief Development Officer)inGautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)
Co-investorsBerkeley FrontierIaso VenturesThe Column GroupViking GlobalYsios CapitalAlexandria+8 more
Noah Medical develops robotic and software solutions for diagnostic bronchoscopy procedures, designed to enable earlier lung cancer diagnosis with improved accuracy.
HealthtechMedical DevicesRoboticsSilicon Valley, US
Jian Zhang(Founder & CEO)Enrique RomoinFrank Grilloin
Co-investors1955 CapitalChina Growth CapitalProsperity7 VenturesShangBay Capital LLC
Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection.
BiotechDigital HealthHealthtechMedical Devices
Eli Frydman(President EMEA)
Co-investorsGefen CapitalOrbiMedRA CapitalAurum Ventures MKIBlackRockLilly Asia Ventures+1 more
Acquired by Genmab in April 2024.
Co-investorsB Capital GroupB4 CapitalHongShan Capital GroupLAVLifeSci Venture PartnersLilly Asia Ventures+2 more
Sciwind Biosciences is a commercial-stage biopharmaceutical company that discovers, develops, and delivers therapeutics focused on metabolic and weight management conditions, serving patients globally.
BiotechHealthtech
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BrightechChemLexCleveland DiagnosticsEDGEEdge MedicalFong's EngineeringJeisis MedicalKali TherapeuticsKangji MedicalMediLinkNoah
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.